Biorestorative Therapies, Inc. (BRTX) Reports Q2 Loss, Tops Revenue Estimates
BioRestorative Therapies(BRTX) ZACKS·2024-08-14 06:56
Biorestorative Therapies, Inc. (BRTX) came out with a quarterly loss of $0.50 per share versus the Zacks Consensus Estimate of a loss of $0.56. This compares to loss of $0.77 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 10.71%. A quarter ago, it was expected that this company would post a loss of $0.51 per share when it actually produced a loss of $0.53, delivering a surprise of -3.92%. Over the last four quarters, the com ...